PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för vilanterol. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

7 hits

Bibliografisk träff 2013-07-02

Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD.

Donohue JF, Maleki-Yazdi MR, Kilbride S, Mehta R, Kalberg C, Church A.

Respir Med · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.rmed.2013.06.001

Bibliografisk träff 2013-04-01

β2-agonist therapy in lung disease.

Cazzola M, Page CP, Rogliani P, Matera MG.

Am J Respir Crit Care Med · review; journal article · DOI 10.1164/rccm.201209-1739pp

Bibliografisk träff 2013-03-27

Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study.

Mehta R, Kelleher D, Preece A, Hughes S, Crater G.

Int J Chron Obstruct Pulmon Dis · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.2147/copd.s40859

Bibliografisk träff 2012-12-17

Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial.

Kelleher DL, Mehta RS, Jean-Francois BM, Preece AF, Blowers J, Crater GD, Thomas P.

PLoS One · research-article; randomized controlled trial; journal article · DOI 10.1371/journal.pone.0050716

Bibliografisk träff 2012-10-04

Metabolism and disposition of vilanterol, a long-acting β(2)-adrenoceptor agonist for inhalation use in humans.

Harrell AW, Siederer SK, Bal J, Patel NH, Young GC, Felgate CC, Pearce SJ, Roberts AD, Beaumont C, Emmons AJ, Pereira AI, Kempsford RD.

Drug Metab Dispos · research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.112.048603

Bibliografisk träff 2012-08-31

28-Day safety and tolerability of umeclidinium in combination with vilanterol in COPD: a randomized placebo-controlled trial.

Feldman G, Walker RR, Brooks J, Mehta R, Crater G.

Pulm Pharmacol Ther · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.pupt.2012.08.007

Bibliografisk träff 2012-07-01

The efficacy and safety of the novel long-acting β2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial.

Hanania NA, Feldman G, Zachgo W, Shim JJ, Crim C, Sanford L, Lettis S, Barnhart F, Haumann B.

Chest · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1378/chest.11-2231